Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Bio-Works Technologies Confirms Production Scale Order Worth 2.7 mSEK to Leading Swedish CDMO

Bio-Works Technologies

Today, Bio-Works Technologies AB has confirmed a significant production-scale order valued at 2.7 million SEK from a prominent Contract Development and Manufacturing Organization (CDMO) based in Sweden. This order represents a strong endorsement of Bio-Works’ advanced chromatographic resins used in the purification of biomolecules.

The collaboration with the CDMO further solidifies Bio-Works’ position as a trusted supplier of high-quality and scalable purification solutions for the biopharma industry. The order will see Bio-Works’ WorkBeads™ products integrated into the client’s production processes, enhancing the efficiency and quality of biomolecule purification at a commercial scale.

Lone Carlbom, CEO of Bio-Works Technologies, commented on the order:
"This significant production-scale order is a testament to the quality and reliability of our WorkBeads™ resins. We are proud to partner with such a reputable CDMO in Sweden, and this collaboration underscores our ongoing commitment to delivering innovative solutions that meet the growing demands of the biopharmaceutical industry. As the industry continues to expand, we are well-positioned to support our partners in achieving excellence in bioprocessing."
This order marks another key milestone in Bio-Works Technologies’ growth trajectory, as the company continues to expand its footprint within the global biopharma purification market. The use of Bio-Works' proprietary technology in production processes will enable faster, more efficient manufacturing of biotherapeutics, ultimately benefiting patients around the world.

Contacts:
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Lone Carlbom, CEO, e-mail: lone.carlbom@bio-works.com, phone: +46(0)8-502 705 84.

About Bio-Works
Bio-Works enables Biotech companies to achieve their goals for purification of biomolecules. We support our customers, from laboratory research to commercial production, and together we implement efficient and robust solutions for bioprocessing. Our ambition is to be a trusted and dynamic partner in an industry characterized by growth and development.

Bio-Works’ headquarters, with R&D and manufacturing, is located in Uppsala Business Park in Uppsala, Sweden. We supply products globally, through a combination of direct sales and via distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Spotlight Stock Market ("BIOWKS"). For more information, visit www.bio-works.com.

Attachments
Bio-Works Technologies Confirms Production Scale Order Worth 2.7 mSEK to Leading Swedish CDMO

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.